The Biosensor is a Platform for Multiple Diagnostic Tests

World-first Organic Thin Film Transistor (OTFT) technology

The Biosensor Platform is a small, printable organic strip designed to put the power of accurate, timely diagnosis in the hands of patients and their primary health practitioners.

By altering the detection element (region A) depending on the specific analyte of interest, we have the ability to produce a whole portfolio of non-invasive, real-time, saliva-based diagnostic tests.

Because both the core OTFT sensing element and the mechanism of action remains the same, tests developed from the Biosensor Platform have the potential to be printed at scale, at a low cost.

Behind the Technology

Meet the team at the Centre for Organic Electronics behind the biosensor technology.

Our Journey

The story of the Biosensor

 
RESEARCH BEGINS
Professor Paul Dastoor and University of Newcastle team began research into conducting polymers.
1997
 
IP FILED
IP for Organic Thin-Film Transistor (OTFT) technology filed.
2013
 
PUBLICATION
“Detection of saliva-range glucose concentrations using organic thin-film transistors”, Applied Physics Letters, 105, 043303 (2014).
2014
 
IP ACQUIRED
The iQ Group Global acquires OTFT technology for diabetes management and accelerates development into medical device. 
2016
 
US PATENT GRANTED
Patent: US 9,776,199B2
Original IP protected to 2033, with more patents to be filed. Ongoing development by original scientific team.
2017
 
GBS INC.
Leadership team established for GBS Inc.

BIOSENSOR PLATFORM PIPELINE EXTENDED
The iQ Group Global announces extension of research and development of biosensor for additional indications including cancer, allergen and hormone biomarkers.

CHINA PATENT GRANTED
Patent: CN201380022888.2
2018
 
PUBLICATION
GenomeWeb acknowledges the Saliva Glucose Biosensor as leading the race to the “holy grail” of life sciences.
2019
 
FDA REGULATORY SUBMISSION
commences for De Novo classification of the Saliva Glucose Biosensor.

COVID-19 ANTIBODY PROGRAM
Collaboration with Wyss Institute for Biologically Inspired Engineering at Harvard University commences for COVID-19 antibody program.
2020

The University of Newcastle, Australia

About the Centre for Organic Electronics

The biosensor was invented at the Priority Research Centre for Organic Electronics at The University of Newcastle, Australia.

The Centre for Organic Electronics is the first of its kind in Australia. It is an exciting new initiative focusing on the development of new electronic devices at the intersection between semiconductors and plastics.

The Centre focuses on the scientific challenges in the development of organic electronics, with massive potential for the next generation of environmentally friendly energy sources, photonics and biosensors.

Future Tests

Development has commenced on an entire portfolio of tests including cancer markers, hormones and allergens.

Sign Up

Register for email alerts for the latest on the Biosensor Platform and GBS Inc.

  • This field is for validation purposes and should be left unchanged.